DABRAFENIB vs DACLIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs DACLIZUMAB: Safety Overview
| Metric | DABRAFENIB | DACLIZUMAB |
|---|---|---|
| Total FAERS Reports | 19,305 | 2,801 |
| Deaths Reported | 4,165 | 193 |
| Death Rate | 21.6% | 6.9% |
| Hospitalizations | 5,325 | 835 |
| Average Patient Age | 58.3 yrs | 45.7 yrs |
| % Female Patients | 48.0% | 81.5% |
| FDA Approval Date | Mar 16, 2023 | N/A |
| Manufacturer | Novartis Pharmaceuticals Corporation | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |